Biosolution Co.Ltd (086820) — Cash Flow Reinvestment Rate

Latest as of September 2025: 2.23x

Biosolution Co.Ltd (086820) has a Cash Flow Reinvestment Rate of 2.23x as of September 2025, reinvesting ₩38.75 Million (capex ₩22.15 Million plus investments ₩16.60 Million) from operating cash flow of ₩17.41 Million. See free cash flow generation of Biosolution Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.23x
(Capex + Investments) / Operating CF

Total Reinvested

₩38.75 Million
Capex + Investments

Operating Cash Flow

₩17.41 Million
KRW

Capital Expenditures

₩22.15 Million
KRW

Biosolution Co.Ltd Cash Flow Reinvestment Rate (2018–2023)

Historical reinvestment intensity for Biosolution Co.Ltd across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Biosolution Co.Ltd.

Annual Cash Flow Reinvestment Rate for Biosolution Co.Ltd (2018–2023)

Year-by-year capital reinvestment analysis for Biosolution Co.Ltd. See financial agility of Biosolution Co.Ltd to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2023 5.02x ₩10.85 Billion ₩2.16 Billion ₩1.16 Billion ▼ -97.7%
2021 214.45x ₩17.86 Billion ₩83.29 Million ₩663.15 Million ▲ +411.1%
2018 41.96x ₩43.06 Billion ₩1.03 Billion ₩707.50 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow